Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New online therapy aims to ease cancer Survivors' fear of recurrence

NCT ID NCT04287218

Symptom relief Sponsor: Vejle Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Aug 21, 2026 · Updated 1 time

Summary

This study tests an online cognitive therapy program, guided by a therapist, to help colorectal cancer survivors who have finished treatment reduce their fear of the cancer returning. The program includes educational text, exercises, and videos. Researchers will compare it to standard care in 200 Danish survivors to see if it lowers anxiety and improves well-being.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
therapist-guided internet-delivered cognitive therapy (TG-iConquerFear)
What this could lead to
If it works, this could provide an accessible, effective way to help colorectal cancer survivors manage fear of recurrence, improving their quality of life.
What could go wrong
This is a relatively small trial in one country, and the intervention requires internet access and Danish literacy. The therapy may not work for everyone, and results may not apply to other cancer types or populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

95 people

The number who actually took part.

Started

May 2023

Finished

Jul 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Completed curative intent colorectal cancer treatment with surgery and/or radiation and/or adjuvant chemotherapy between 1 March 2014 and 31 December 2018 * No history of recurrence after primary operation * Fear of Cancer Recurrence Inventory score of 22 or above (14) * Age 18 or above * Reads and understands Danish * Access and ability to use Internet Exclusion Criteria: * Cancer recurrence at any follow-up * Inability to comply with the protocol due to severe psychiatric, cognitive disorder or substance abuse identified during telephone interview * As the intervention is web-based, participants without knowledge of or access to the Internet will be excluded from the RCT (including dyslexia).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Anxiety are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

anxiety anxiety disorder cancerophobia colorectal cancer colorectal neoplasm hypochondriasis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Anxiety Bodily distress syndrome Colorectal cancer Fear of cancer recurrence Health anxiety

Contacts and locations

Locations

  • Vejle Hospital, University Hospital of Southern Denmark

    Vejle, 7100, Denmark

More trials for these conditions

Other studies related to the condition(s) this trial covers.